首页> 美国卫生研究院文献>Drug Design Development and Therapy >Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
【2h】

Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data

机译:甲氯乙胺凝胶局部治疗真菌病样真菌性皮肤T细胞淋巴瘤的临床潜力:当前疗效和安全性数据综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations.
机译:氮芥子气是一种化学治疗剂,在治疗皮肤T细胞淋巴瘤方面具有公认的安全性和有效性。在过去的40年中,对氮芥菜配方和治疗方案的开发进行了广泛的研究。在最近的5年中,已经开发了一种新的凝胶制剂,其与迟发型超敏反应的减少有关。这篇综述的作者发现,尽管凝胶制剂可以减少过敏性接触性皮炎,但这种优势已被更多数量的刺激性接触反应和降低的完全缓解率所取代。凝胶制剂的完全响应率为13.8%,与类似浓度的水基制剂相比,功效降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号